Hypoxia induces cellular adaptation largely through hypoxia-inducible factors, particularly HIF-1α, which drive the transcription of genes involved in angiogenesis, metabolic reprogramming, and EMT, thereby enhancing cancer cell invasiveness and resistance to therapy [60]. This evidence concerns the gene HIF1A and cancer.